--- title: "Weekly Recap | Innodata +12.44%, consensus target above spot" type: "News" locale: "en" url: "https://longbridge.com/en/news/302952040.md" description: "Innodata rose 12.44% this week to close at $59.39, while the S&P 500 slipped 0.47%, putting the stock ahead of the benchmark by about 12.91 percentage points. The week’s range was 15.18% and the move was back-loaded: Monday opened lower and tested $52.75, Tuesday stabilised, Wednesday jumped on volume to close at $60.56, Thursday pushed to a high of $61.16 before easing, and Friday traded between $58.00 and $60.88 to settle at $59.39." datetime: "2026-10-24T06:30:56.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/302952040.md) - [en](https://longbridge.com/en/news/302952040.md) - [zh-HK](https://longbridge.com/zh-HK/news/302952040.md) generator: "portal-rs" --- # Weekly Recap | Innodata +12.44%, consensus target above spot ## The Week Innodata rose 12.44% this week to close at $59.39, while the S&P 500 slipped 0.47%, putting the stock ahead of the benchmark by about 12.91 percentage points. The week’s range was 15.18% and the move was back-loaded: Monday opened lower and tested $52.75, Tuesday stabilised, Wednesday jumped on volume to close at $60.56, Thursday pushed to a high of $61.16 before easing, and Friday traded between $58.00 and $60.88 to settle at $59.39. ## Key Events The week’s news centred on the repricing of small-cap AI names. On Tuesday, brokerages were reported to carry an average price target of $116.67 for Innodata, the same day that coverage highlighted a pullback across AI-adjacent small caps following Akamai’s $11.6 billion deal. On Wednesday, Innodata was named alongside CHGA, PENG and AIP as one of four companies capitalising on infrastructure and agentic AI, with the stock among the top ten US gainers that day. Friday’s coverage grouped Innodata with BBAI and SOUN as small-cap AI stocks with more than 88% upside ahead of earnings. The company itself did not report material operational or regulatory news this week, leaving the share-price move closely tied to the broader AI small-cap rotation. ## Analyst Ratings Four brokers cover Innodata: three rate it buy and one rates it overweight, with no hold, underweight or sell ratings; the consensus rating is strong buy. The consensus target is $122.75, about 106.68% above the current price of $59.39. Targets range from $111 to $140, suggesting some disagreement between the low and high ends. Within the research and consulting services industry, Innodata ranks 24th out of 40 names, in the lower-middle segment. ## The Week Ahead The main event ahead is Innodata’s fiscal Q3 2026 results on 5 November, due after market close, with estimates of $0.1817 EPS and $84.42 million in revenue. Before that, next week brings the Dallas Fed manufacturing index, durable goods orders and consumer confidence data, all of which could shape risk appetite for AI small caps. Further out, fiscal 2026 annual results are scheduled for 25 February 2027. ## In Short This week’s advance tracked the broader repricing of AI small caps, with the key move coming in Wednesday’s volume-driven breakout that faded by Friday. Brokers’ outlook is skewed toward the upside: the consensus rating and target both sit well above the current price, though the industry ranking shows Innodata is not at the top of sector consensus. The latest daily flow snapshot shows large-lot money turning net seller while medium and small orders were net buyers, pointing to a split in positioning. The question now is whether upcoming earnings can justify the roughly 43.9x P/E multiple, and how macro data next week feeds into the sector’s risk appetite. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [INOD.US](https://longbridge.com/en/quote/INOD.US.md) ## Related News & Research - [Innodata (INOD) Dropped, So What Is Driving Attention Now?](https://longbridge.com/en/news/302180969.md) - [Innodata consensus price target raised by 11.22% to 109,71 €](https://longbridge.com/en/news/302994819.md) - [OmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at Conference](https://longbridge.com/en/news/302976846.md) - [Greenbrier (GBX) to report earnings tomorrow: here is what to expect](https://longbridge.com/en/news/302976097.md) - [Amazon.com, Inc. $AMZN Stock Sold by Cohen Klingenstein LLC](https://longbridge.com/en/news/302980467.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**